نتایج جستجو برای: alzheimer disease ad

تعداد نتایج: 1556084  

Journal: :JAMA neurology 2013
Matthew Harms Bruno A Benitez Nigel Cairns Breanna Cooper Paul Cooper Kevin Mayo David Carrell Kelley Faber Jennifer Williamson Tom Bird Ramon Diaz-Arrastia Tatiana M Foroud Bradley F Boeve Neill R Graff-Radford Richard Mayeux Sumitra Chakraverty Alison M Goate Carlos Cruchaga

IMPORTANCE Hexanucleotide repeat expansions in the chromosome 9 open reading frame 72 (C9orf72) gene underlie a significant fraction of frontotemporal dementia and amyotrophic lateral sclerosis. OBJECTIVE To investigate the frequency of C9orf72 repeat expansions in clinically diagnosed late-onset Alzheimer disease (AD). DESIGN, SETTING, AND PATIENTS This case-control study genotyped the C9o...

Journal: :Annals of neurology 2017
Chin Hong Tan Bradley T Hyman Jacinth J X Tan Christopher P Hess William P Dillon Gerard D Schellenberg Lilah M Besser Walter A Kukull Karolina Kauppi Linda K McEvoy Ole A Andreassen Anders M Dale Chun Chieh Fan Rahul S Desikan

Identifying asymptomatic older individuals at elevated risk for developing Alzheimer disease (AD) is of clinical importance. Among 1,081 asymptomatic older adults, a recently validated polygenic hazard score (PHS) significantly predicted time to AD dementia and steeper longitudinal cognitive decline, even after controlling for APOE ɛ4 carrier status. Older individuals in the highest PHS percent...

2013
Günther Robert Norman Jones

HISTORICAL BACKGROUND The clinical recognition of a form of dementia closely resembling Alzheimer's disease dates from around 1800. The role of analgesics derived from coal-tar in the spread of the pandemic is traced in terms of the introduction of phenacetin (PN) in 1887; its nephrotoxicity; the observation of lesions characteristic of the disease by Fischer and Alzheimer; the discovery of par...

Journal: :مجله علوم اعصاب شفای خاتم 0
niloofar imani neuroscience department, mashhad university of medical sciences, mashhad, iran

alzheimer’s disease (ad) is a neurodegenerative disease that is the most common type of dementia.ad includes 60_80% of dementia and most people with ad have more than 65 years old.ad causes losing neuronal activity by abnormal proteins. plaques of beta-amyloid and tangles of “tau” protein can lead to ad. recently evidence has found that ad may come from outside of central nervous system (cns) a...

Asie Shojaee, Fataneh Hashem Dabaghian, Mehdi Mehdizadeh, Nima Molavi, Ronak Shabani, Sara Soleimani Asl, Zahra Taslimi,

Introduction: The Alzheimer Disease (AD) is the most common form of dementia that leads to memory impairment. As the oxidative stress plays an important role in AD pathogenesis, the current study aimed at examining the protective effects of Cyperus Rotundus as an antioxidant on amyloid β (Aβ) -induced memory impairment.   Methods: Twenty-eight Wistar male rats received intrahipp...

Non-steroidal anti-inflammatory drugs (NSAIDs) identified effective in many diseases. One of which is neurodegenerative diseases including Alzheimer disease (AD). In this study gross alteration of gene expression in AD mice by ibuprofen treatment is investigated via Protein-protein interaction network (PPI) analysis. Expression profiling of microarray dataset GSE67306 was retrieved from GEO dat...

Akram Eidi, Banafshe Esmaeilzade, Fatima Moghani Ghoroghi, Mahmood Barati, Maliheh Nobakht, Samira Gilanchi, Soraya Mehrabi,

Background: The seladin-1 (selective Alzheimer disease indicator-1), also known as DHCR24, is a gene found to be down-regulated in brain region affected by Alzheimer disease (AD). Whereas, hair follicle stem cells (HFSC), which are affected in with neurogenic potential, it might to hypothesize that this multipotent cell compartment is the predominant source of seladin-1. Our aim was to evaluate...

Journal: :International journal of pharmaceutical research and allied sciences 2021

Alzheimer’s disease (AD) is a progressive neurodegenerative, primarily concerned and leading cause of mortality worldwide which has no cure so far, the world. The progresses from memory loss to cognitive decline gradually. severity grows up mild, moderate severe. Hallmarks research AD reported, are identification amyloid-beta (Aβ) plaques tau protein tangles between within neuronal c...

2016
Rostam Saifadini Haleh Tajadini Rasool Choopani Mitra Mehrabani Mohamad Kamalinegad Aliakbar Haghdoost

CONTEXT Alzheimer disease (AD) is the most common cause of dementia. In regards to the world's aging population, control and treatment of AD will be one of the major concerns of global public health in the next century. Alzheimer disease was not mentioned with the same phrase or its equivalent in traditional medical texts. The main of present paper was to investigate symptoms and causes of alzh...

Journal: :Journal of Geriatric Neurology 2022

The number of Alzheimer disease (AD) is increasing worldwide and it still the most common cause dementia. However, there are limited treatment option with just symptomatic medications. Therefore new modifying drugs were in great need for many years AD treatment. Recently, aducanumab which beta amyloid targeted immunotherapy, has been approved by US Food Drug Administration AD. Although question...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید